Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “PESSARY”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,261 records · Page 70Linked to original sources
PubMedDate not supplied

Home treatment for women with stress urinary incontinence.

Urinary incontinence is an unpleasant, unwanted and distressing problem that is common among women in the UK. A recent study (Hunskarr et al, 2004) estimated that 10 million women in the UK suffer with urinary incontinence. Stress urinary incontinence (SUI) is the most common form, affecting four million women. The International Continence Society defines SUI as 'the complaint of involuntary leakage [of urine] on effort or exertion, or on sneezing or coughing' (Abrams et al, 2002).

Duloxetine Hydrochloride↗
PubMedDate not supplied

Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections.

Forty-one adult women with acute lower urinary tract infections (UTI) were randomly treated for three days with norfloxacin or trimethoprim/sulfamethoxazole (TMP/SMX). Infection was eradicated in 100% of norfloxacin-treated patients and in 95% of TMP/SMX-treated patients. UTI recurred in 29% of patients treated with norfloxacin and in 41% of those treated with TMP/SMX. Post-therapy vaginal administration of lactobacillus suppositories resulted in a recurrence rate of UTI of only 21%, while in patients given sterilized skim-milk suppositories the recurrence rate was 47%. This study indicates that lactobacillus vaginal suppositories are safe and may be effective in reducing the recurrence of UTI following antimicrobial therapy.

Adult↗
PubMed2004

Genital prolapse.

Explore the source record for details and available documents.

Administration, Intravaginal↗
PubMedDate not supplied

Discreet products for women with urinary incontinence.

It is estimated that 10 million women in the UK suffer with urinary incontinence (Hunskarr et al, 2004). Many women consider bladder weakness to be an inevitable consequence of childbirth or the menopause. Haslam (2004) reported on a telephone survey that examined whether women were aware of stress urinary incontinence, their attitude to it and the impact it had on their daily lives. In the UK, 505 women were interviewed, 206 of whom responded positively to a question about symptoms of stress urinary incontinence, giving a prevalence rate of 41 per cent. There is also evidence that most patients with urinary incontinence do not present to their doctors

Adaptation, Psychological↗
PubMed1992

Urinary incontinence in the aged, Part 2: Management strategies.

Treatments for urge incontinence associated with uninhibited bladder contractions include medications with anticholinergic and smooth muscle relaxant properties as well as habit training, bladder retraining, contingency therapy, and biofeedback. Pelvic floor (Kegel) exercises improve stress incontinence in 60 to 90% of female patients. For patients who fail to improve with pelvic floor exercises, a combination of an alpha-adrenergic agent and conjugated estrogen is recommended. Surgery is particularly effective in elderly women with significant pelvic prolapse. Management of overflow incontinence requires surgery or intermittent/chronic catheterization. Functional incontinence may be improved with correction of the underlying disorder and availability of a motivated caregiver.

Aging↗
PubMed1992

Prostaglandin for enhancing bladder function after vaginal surgery. Does it work?

Fifty women underwent vaginal hysterectomy with or without anterior and posterior colporrhaphy. After the operations the women were allocated randomly to one of three groups. One group (17 patients) received daily vaginal suppositories of 10 mg of prostaglandin E2. The second group (15) received a daily intravesical solution of 50 micrograms of prostaglandin F2 alpha dissolved in 100 mL of normal saline. The third group (18) received a daily instillation of 100 mL of saline and served as the control group. The postvoiding residual urinary volume was checked daily through a suprapubic catheter, which was removed once the residual volume was less than 50 mL. The prostaglandin did not shorten the time required for postoperative bladder drainage. The rates of febrile morbidity and hospital stay were the same in all three groups. Since most of the women in the study voided spontaneously within three days, the "sit and wait" approach seems reasonable in such patients, and prophylactic treatment to enhance bladder function after vaginal operations does not seem justified.

Administration, Intravesical↗
PubMed2005

Genital prolapse.

Explore the source record for details and available documents.

Administration, Intravaginal↗
PubMed1992

[Experience in the use of vaginal and intracervical enzaprost suppositories in preparation for labor].

To improve the efficacy of prelabor treatment of pregnant women with some obstetrical abnormalities, such as over-term pregnancy, AB0- and Rh-isosensitization, anemia, gestosis of the second half of pregnancy, vaginal and intracervical suppositories containing 0.1 mg of enzaprost were administered to 102 women for 1-5 days. In 30 (29.4%) cases such treatment induced spontaneous labor. In 64 (62.7%) women labor was induced by deoxy-amino oxytocin, and in 8 (7.8%) women this latter drug had to be administered repeatedly to induce labor. The babies born to the women under observation had the Apgar score of 6-10, 92 (90.2%) of them had the score of 8-10. No stillbirths or early infant mortality cases were recorded. Therefore prelabor treatment with vaginal or intracervical suppositories with enzaprost is effective and safe for both mother and newborn.

Apgar Score↗
PubMed2005

Not the surgery for a young person: women's experience with vaginal closure surgery for severe prolapse.

INTRODUCTION: Vaginal prolapse can be debilitating, due to pelvic organ prolapse and herniation of the bladder, uterus, intestines and/or support tissues in the vaginal opening. However, there is little published information that documents women's experiences in the months and years after surgery to correct prolapse. OBJECTIVE: This phenomenologic study aimed to increase understanding of the specific experiences that patients report after vaginal closure surgery. METHOD: Participants were recruited via a mailing to surgical patients from a large urogynecologic practice. Semi-structured interviews were tape-recorded and transcribed for analysis. RESULTS: Six women participated in the study. After analyzing the results, five major themes emerged: awareness and confusion, feeling alone in silence, trusting recommendation, acceptance of changed sexuality, and still coping. CONCLUSIONS: This small study shows that vaginal closure affects an intimate body part and can impact self-image, but the women did not regret their changed sexuality. The larger issues for these women were ones of communication, information, and isolation, particularly during their followup care.

Adaptation, Psychological↗
PubMed1991

[Observations in vivo on spermicidal effect of nonoxynol-9 contraceptive in forms of effervescent suppository and film].

Spermicidal effect of nonoxynol-9 contraceptive in forms of efferscent suppository and film trade in China were studied in vivo. There were noticeable differences on the spermicidal effect in vivo between the two types and different doses. This study indicated that nonoxynol-9 efferscent suppository was more effective than the np-9 film in spermicidal efficacy. (1) No live sperm was found in the samples of vaginal and cervical mucus in the 20 cases of the suppository group. (2) There were live sperms in the samples of vaginal mucus of 6 cases and cervical mucus of 3 cases among the 20 cases of the film group.

Adult↗
PubMedDate not supplied

Pelvic organ prolapse.

Pelvic organ prolapse, a condition in which the ligaments and muscles that suspend the vagina within the pelvic cavity weaken or break, is a frequent cause of urinary and fecal incontinence. Stigma, embarrassment and the belief that pelvic organ prolapse is a natural part of aging prevents many women from seeking treatment. Medical imaging modalities such as defecography, dynamic magnetic resonance imaging and ultrasound help health care providers make effective treatment decisions.

Diagnostic Imaging↗